Packaging compliance needs two different representatives: one for the whole EU, one for every member state you sell into

Regulation (EU) 2025/40 on packaging and packaging waste has applied directly in all 27 member states since 12 August 2026, replacing Directive 94/62/EC. There is no blanket exemption for medical device packaging — only the sterile barrier system receives conditional relief on two sustainability metrics. The mistake Chinese exporters make most often is not a failed test report: it is treating an existing MDR authorised representative as the PPWR representative.

1. Three "representatives", three different roles

This is the table to remember. Different legal bases, different duties, different territorial scope. One mandate does not substitute for another.

  MDR / IVDR authorised representative PPWR Article 17 representative PPWR Article 45(3) EPR representative
Legal basis MDR Art. 11 / IVDR Art. 11 PPWR Art. 17 PPWR Art. 45(3)
Scope Device conformity, technical documentation, liaison with authorities Holds packaging technical documentation and DoC, answers market surveillance Registers you in the national producer register, reports volumes and materials, pays EPR fees
Territory One mandate, whole EU One mandate, whole EU One per member state of sale
Mandatory? Yes, for non-EU manufacturers Optional Yes, where the producer has no establishment in that state
Do the arithmetic: Article 45(3) is counted per country. Selling into Germany, France, Italy, Spain and Poland means five written mandates, five registrations, five annual fees. Publicly quoted representative fees run roughly EUR 600 to 5,000 per country per year, depending on the state and the provider. Registration also takes lead time — national registers generally will not process a filing that arrives after your goods are already on sale.

One rumour to read carefully: in December 2025 the Commission proposed COM(2025) 982, suspending the Article 45(3) obligation until 1 January 2035. That relief is drafted for EU-established producers only; third-country exporters are expressly left out. As of publication the proposal has not been adopted and not been published in the OJEU. "I heard it is being suspended" is not a plan.

2. What device packaging is actually exempt from

The premise first: PPWR contains no "medical packaging is out of scope" clause. The sterile barrier system is packaging, and Annex I lists it as such. Relief applies to two metrics only, and it is conditional.

Packaging level Examples PPWR treatment
Primary (contact-sensitive) Sterile barrier system, individual mask pouch Art. 6(11)(b) relief from design-for-recycling, Art. 7(4)(b) relief from recycled content; everything else applies
Secondary (sales) Folding carton, paper or plastic inserts Fully in scope
Tertiary (transport) Shipping cartons, stretch film, cushioning, pallets Fully in scope
The exemption is a scalpel, not a shield. It removes the two hardest targets — putting recyclate into a sterility-critical material, and redesigning a barrier structure to recycling criteria — and leaves heavy-metal limits, minimisation, the Declaration of Conformity, EPR registration and labelling fully in force. The Article 6 relief must also be reviewed by 1 January 2035; it is not permanent. And a claimed derogation has to be justified and documented in the technical file — it is not automatic.

3. What is actually being checked since 12 August

  • Heavy metals: lead, cadmium, mercury and hexavalent chromium combined ≤ 100 mg/kg, across every packaging component — cartons, inserts, printing inks, adhesives, laminating film, labels, cushioning. A finished-device RoHS report does not substitute for packaging material testing, and this is the most common gap. Authorities expect testing per homogeneous material with reports retained.
  • Declaration of Conformity: Art. 39 with Annex VIII, issued per packaging model. Identical parameters may share one DoC; different parameters may not. Technical documentation per Annex VII must be kept 5 years for single-use and 10 years for reusable packaging. Reports and self-assessments from the old Directive do not replace the PPWR conformity file.
  • EPR registration: Art. 44 requires entry in the national producer register of each member state of first making available — LUCID in Germany, Citeo in France, CONAI in Italy. There is no single EU-wide certificate. From the same date, online marketplaces must verify registration and can delist unregistered sellers.

On PFAS: PPWR limits apply to food-contact packaging only. Ordinary medical device packaging falls outside them unless the packaging also contacts food. Worth knowing when a supplier uses PFAS to sell you testing you do not legally need — though inks, coatings and adhesives remain subject to the general duty under Art. 5 to minimise substances of concern.

On stock: the reference point is release into free circulation by customs. Packaging placed on the market before 12 August 2026 and still in the channel may continue to be sold without recall; anything produced but not yet placed must meet the new rules. Goods on the water are not "not yet placed".

4. 2028 and 2030: not urgent yet, but slowest to fix

  • 12 August 2028: harmonised material-composition labelling showing material and disposal route.
  • 1 January 2030: recyclability grade A/B/C (≥70% recyclable, grade D barred), minimum recycled content in plastic packaging, minimisation and the 50% empty-space cap, plus the single-use formats banned under Annex V.
  • 1 January 2038: only grade A/B (≥80%) packaging may be placed on the market.

For device manufacturers the item to watch today is plastic lamination on folding cartons: film and board are permanently bonded, cannot be separated in paper recycling, and it is the single biggest drag on your 2030 grade. Removing it, switching to a water-based varnish or changing carton geometry involves tooling, supplier changes and re-validation of sterilisation compatibility — typically 12 to 18 months. Starting in 2029 is too late.

5. Who carries the duty depends on how you ship

Route to market Producer for EPR purposes What you must do
Sold through an EU importer The EU importer (Art. 18) Supply full packaging BOM, material and weight data, test reports, design documentation; run the conformity assessment and issue the DoC yourself. The importer cannot push its duty upstream, and you cannot push yours downstream.
Direct cross-border sales You are Appoint an Art. 45(3) representative in every country of sale to register, report and pay. Marketplaces, freight forwarders and customs brokers do not inherit your producer status.

6. The 90-day sequence

  • Days 0–30: build packaging BOMs for your main SKUs layer by layer, and send homogeneous materials for heavy-metal testing to close the August gap.
  • Days 30–60: confirm the route to market for each product line — with or without an EU importer — because that decides whether you supply data or appoint representatives. Then count your countries of sale: that number is how many Art. 45(3) mandates you need.
  • Days 60–90: issue DoCs, build Annex VII technical files, register country by country. Start the 2030 structural workstream in parallel, beginning with your three highest-volume SKUs.

How we can help

STATELAB CERT GmbH (North Rhine-Westphalia, Germany) acts as MDR/IVDR authorised representative and as PPWR Article 17 representative and Article 45(3) EPR representative. We also provide packaging compliance gap analysis, BOM and test-scope mapping, DoC and technical documentation, and multi-country EPR registration for Chinese manufacturers exporting to the EU.